AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ATAI Life Sciences N.V. Director's Dealing 2021

Jun 18, 2021

32049_dirs_2021-06-17_f2c60e25-0e87-4751-93b4-64db895f68e8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ATAI Life Sciences B.V. (ATAI)
CIK: 0001840904
Period of Report: 2021-06-17

Reporting Person: Auerbach Michael (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	5559808	Indirect

Footnotes

F1: Mr. Auerbach serves as General Partner of Subversive ATAI LLC, a multi-member limited liability company. Mr. Auerbach has sole voting and investment power with respect to the shares held by Subversive ATAI LLC.